Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Oct 22, 2025
Date Accepted: Jun 9, 2026

The final, peer-reviewed published version of this preprint can be found here:

A Personal Health App and Wearable Co-Design Framework for Rare and Complex Diseases: User-Centered, Collaborative Co-Design Study

Goodday SM, Karlin E, Sorenson M, Yang R, Gordon P, Opoku C, Vuong D, Wilson J, McKenzie D, Piccotti J, Tavanti M, Fitzgerald M, Re'em Y, Wei H, Golden M, Morgan D, Manion M, Mosquera R, Shivas T, Hoover E, Peck A, Peck N, Ravarow Z, Bjornson-Pennell H, Stratton A, Anova Sahoo S, Arbittier D, Arbittier E, Goff R, Harvin-Graham D, Howard N, Knudsen C, Oldham MH, Friend S

A Personal Health App and Wearable Co-Design Framework for Rare and Complex Diseases: User-Centered, Collaborative Co-Design Study

JMIR Mhealth Uhealth 2026;14:e85425

DOI: 10.2196/85425

PMID: 42475673

A personal health app and wearable codesign framework for rare and complex diseases: Protocol for a user centered, collaborative codesign methodology

  • Sarah Margaret Goodday; 
  • Emma Karlin; 
  • Maddie Sorenson; 
  • Robin Yang; 
  • Paul Gordon; 
  • Caresse Opoku; 
  • Daniel Vuong; 
  • Jenee Wilson; 
  • Diane McKenzie; 
  • Jules Piccotti; 
  • Massimiliano Tavanti; 
  • Megan Fitzgerald; 
  • Yoachai Re'em; 
  • Hannah Wei; 
  • Megan Golden; 
  • Daniel Morgan; 
  • Michele Manion; 
  • Ricardo Mosquera; 
  • Tricha Shivas; 
  • Elise Hoover; 
  • Alison Peck; 
  • Nathan Peck; 
  • Zollie Ravarow; 
  • Heidi Bjornson-Pennell; 
  • Andra Stratton; 
  • Samali Anova Sahoo; 
  • Douglas Arbittier; 
  • Elizabeth Arbittier; 
  • Renee Goff; 
  • Donna Harvin-Graham; 
  • Nancy Howard; 
  • Camille Knudsen; 
  • Mary H Oldham; 
  • Stephen Friend

ABSTRACT

Background:

End-user co-design in the personal digital health technology space (P-DHT) is underdeveloped.

Objective:

The objective of this paper is to describe an ‘end-user’ co-design framework in the development of five prototype personal health apps for patients with different rare and complex diseases.

Methods:

A patient-led, user-centered, and collaborative personal health app plus wearable plug-in co-design methodology was developed. Five prototype apps were developed for end-users with Long COVID, pancreatitis, primary ciliary dyskinesia (PCD), sarcoidosis, and Valosin-containing protein (VCP) disease by a multidisciplinary partnership including patients, app design and development experts, UX experts, clinicians, and patient driven organizations (PDGs). Phase 1 involved a 6-month co-design phase with 5 modules with the PDGs that included the co-development of specifications through group workshops and independent exercises that defined the goals, content, features, and UX of each app. Phase 2 involved the app build out, internal alpha testing, and beta study preparations. Phase 3 involved a usability beta testing study with end-user participants who used the app, and various associated wearable/smart devices (Oura ring, Lumia ear device, Empatica EmbracePlus, and MIR Spirobank Spirometer) for up to 5 months. Participant feedback was documented continuously and systematically centering on the following themes: functionality, usability, harms, benefits, self-explorations, and beta testing study details related to retention and adherence.

Results:

While unique app goals were co-developed by each disease group, a central goal across groups was to develop a personal health app that enables the user to track and follow subjective, self-reported symptoms, objective measures of health, and unique modifiers of symptoms. A total of 239 participant end-users participated in the beta testing pilot study. Enrolment and retention rates were high, ranging from 94% to 100% and 92.2% to 100%, respectively. All active participants gave some form of feedback: there were 257 unique participant suggestions of how to specifically modify or improve the study app experience. Participant feedback themes commonly centered around customization to reduce daily burden, and improve personal tailoring of the app. Participants' desires surrounding symptom displays were heterogeneous.

Conclusions:

Personal health app co-design is rooted in a complex digital landscape that requires a significant amount of upfront effort and time. However, the upfront investment of time can result in rich and diverse end-user feedback that could save time in the app development trajectory to implementation. This paper provides a co-design framework, and the building blocks of five prototype personal health apps with publically available open source code on GitHub. These prototypes could be leveraged for improving understanding of, communicating symptoms of, and providing n-of-1 suggestions for rare and complex diseases, providing benefit to patient communities and individual patients.


 Citation

Please cite as:

Goodday SM, Karlin E, Sorenson M, Yang R, Gordon P, Opoku C, Vuong D, Wilson J, McKenzie D, Piccotti J, Tavanti M, Fitzgerald M, Re'em Y, Wei H, Golden M, Morgan D, Manion M, Mosquera R, Shivas T, Hoover E, Peck A, Peck N, Ravarow Z, Bjornson-Pennell H, Stratton A, Anova Sahoo S, Arbittier D, Arbittier E, Goff R, Harvin-Graham D, Howard N, Knudsen C, Oldham MH, Friend S

A Personal Health App and Wearable Co-Design Framework for Rare and Complex Diseases: User-Centered, Collaborative Co-Design Study

JMIR Mhealth Uhealth 2026;14:e85425

DOI: 10.2196/85425

PMID: 42475673

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.